Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.

被引：0
|
作者：
Schmitt, J. M.
Sommers, S. R.
Fisher, W. B.
Ansari, R. H.
Robin, E. L.
Koneru, K.
McClean, J. W.
Liu, Z.
Hanna, N. H.
机构：
[1] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Med Consultants, Muncie, IN USA
[4] Michiana Hematol Oncol PC, South Bend, IN USA
[5] Community Hosp, Munster, IN USA
[6] Canc Ctr Southern Indiana, Bloomington, IN USA
[7] Med & Surg Specialists LLC, Galesburg, IL USA
[8] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA
[9] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14661
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14661
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A PHASE-II TRIAL OF INTERFERON ALPHA-2A PLUS FLUOROURACIL IN ADVANCED RENAL-CELL CARCINOMA - A HOOSIER ONCOLOGY GROUP-STUDY
    MURPHY, BR
    RYNARD, SM
    EINHORN, LH
    LOEHRER, PJ
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (03) : 225 - 230
  • [42] Phase II study of paclitaxel in patients with advanced gastric cancer.
    Horikoshi, N
    Yamaguchi, K
    Otani, T
    Takiuchi, H
    Sakata, Y
    Taguchi, T
    ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [43] Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer
    Gadgeel, SM
    Shields, AF
    Heilbrun, LK
    Labadidi, S
    Zalupski, M
    Chaplen, R
    Philip, PA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 37 - 41
  • [44] Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase II study
    Fountzilas, G
    Tsavdaridis, D
    Kalogera-Fountzila, A
    Christodoulou, C
    Timotheadou, E
    Kalofonos, C
    Kosmidis, P
    Adamou, A
    Papakostas, P
    Gogas, H
    Stathopoulos, G
    Razis, E
    Bafaloukos, D
    Skarlos, D
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1545 - 1551
  • [45] Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group
    Kim, J. G.
    Sohn, S. K.
    Sohn, Y. S.
    Chae, Y. S.
    Song, H. S.
    Kwon, K. -Y
    Do, Y. R.
    Kim, M. K.
    Lee, K. H.
    Hyun, M. S.
    Ryoo, H. M.
    Bae, S. H.
    Park, K. U.
    Lee, W. S.
    Baek, J. H.
    Chung, H. Y.
    Yu, W.
    BRITISH JOURNAL OF CANCER, 2008, 98 (03) : 542 - 546
  • [46] Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group
    J G Kim
    S K Sohn
    Y S Chae
    H S Song
    K-Y Kwon
    Y R Do
    M K Kim
    K H Lee
    M S Hyun
    H M Ryoo
    S H Bae
    K U Park
    W S Lee
    J H Baek
    H Y Chung
    W Yu
    British Journal of Cancer, 2008, 98 : 542 - 546
  • [47] PHASE-II EVALUATION OF MITOXANTRONE PLUS CISPLATINUM IN PATIENTS WITH ADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    ATIBA, JO
    GREEN, SJ
    HYNES, HE
    OSBORNE, CK
    MILLER, TP
    DAVIDNER, M
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (02) : 129 - 132
  • [48] Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study
    Briasoulis, E
    Kalofonos, H
    Bafaloukos, D
    Samantas, E
    Fountzilas, G
    Xiros, N
    Skarlos, D
    Christodoulou, C
    Kosmidis, F
    Pavlidis, N
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3101 - 3107
  • [49] PhaseII study of gemcitabine, paclitaxel and trastuzumab in metastatic breast cancer; a Hoosier Oncology Group trial.
    Miller, KD
    Sisk, J
    Gize, G
    Nattam, S
    Ansari, R
    Vinson, J
    Sledge, G
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S113 - S113
  • [50] A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: A Hoosier Oncology Group Trial.
    Moore, AM
    Cardenes, H
    Johnson, CS
    Helft, P
    Seitz, D
    Stephens, A
    Tai, DF
    Loehrer, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 339S - 339S
12345